Bayer has discontinued an early-stage clinical gene therapy for a rare genetic disorder in favor of a similar candidate. | Bayer has discontinued an early-stage clinical gene therapy for a rare ...

As more people stay active as they age, overuse injuries are increasing. A non-invasive treatment known as shockwave therapy ...

Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...

Trauma healing shouldn't be a solo battle. Explore a three-level map: inner parts, relationships, and meaning, to know when ...

March 3 (Reuters) - Sequoia Capital-backed Grow Therapy has raised $150 million in fresh funding, valuing the mental health startup at $3 billion, it said on Tuesday. The Series D round, which brings ...

Several senior living providers recently have brought therapy services in-house in an effort to provide residents easy and consistent access to such care and to remove potential access barriers such ...

Your delivery makes all the difference.

RGX-121 was rejected in early February, with Regenxbio listing the primary reasons given by the FDA as concerns about the ability to properly define a patient population, the use of a natural history ...

Sequoia Capital-backed mental health startup Grow Therapy has reached a $3 billion valuation with new funding.

Bridget Williams gathered a group of children together in her barn to show them how to safely give a horse a treat.